Harpoon Therapeutics, Inc. — Form D

Harpoon Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-07. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Alan ColowickDirectorBelmont, CA
Lauren P SilvernailDirectorSouth San Francisco, CA
Joanne P VineyDirectorSouth San Francisco, CA
Luke Nathaniel WalkerExecutive OfficerSouth San Francisco, CA
Luke WalkerExecutive OfficerNashville, TN
Andrew RobbinsDirectorNew York, NY
Joseph BailesDirectorHouston, TX
Julie EastlandDirectorSouth San Francisco, CA
Julie EastlandExecutive OfficerSouth San Francisco, CA
Mark ChinDirectorCambridge, MA
Scott MyersDirectorSouth San Francisco, CA
Jonathan DrachmanDirectorSouth San Francisco, CA
Ronald HuntDirectorSouth San Francisco, CA
Lauren SilvernailDirectorSouth San Francisco, CA
Natalie R SacksExecutive OfficerBerkeley, CA
Mark E ChinDirectorCambridge, MA
Jonathan R DrachmanDirectorSouth San Francisco, CA
Julie R EastlandDirectorSouth San Francisco, CA
Patrick R BaeuerleDirectorSouth San Francisco, CA
Mark R ChinDirectorSouth San Francisco, CA
Holger R WescheExecutive OfficerSouth San Francisco, CA
Gerald McMahonDirectorSouth San Francisco, CA
Gerald McMahonExecutive OfficerSouth San Francisco, CA
Scott R MyersDirectorSouth San Francisco, CA
Ron R HuntDirectorSouth San Francisco, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2023-10-31D$100.2M$100.2M
2018-11-26D$70.0M$70.0M
2017-06-06D$45.2M$25.2M

More